Hypoparathyroidism diagnostic criteria: Difference between revisions
No edit summary |
m Bot: Removing from Primary care |
||
Line 19: | Line 19: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
Line 24: | Line 25: | ||
[[Category:Parathyroid disorders]] | [[Category:Parathyroid disorders]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
Latest revision as of 22:18, 29 July 2020
Hypoparathyroidism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypoparathyroidism diagnostic criteria On the Web |
American Roentgen Ray Society Images of Hypoparathyroidism diagnostic criteria |
Risk calculators and risk factors for Hypoparathyroidism diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
The diagnosis of hypoparathyroidism is made when the following diagnostic criteria are met, hypocalcemia (albumin-adjusted) confirmed on at least two occasions separated by at least 2 weeks, parathyroid hormone (PTH) concentration, by second- or third-generation immunoassay, that is undetectable or inappropriately low (ie, <20 pg/mL) in the presence of hypocalcemia on at least two occasions, phosphate levels in the upper normal or frankly elevated range (helpful but not mandatory), and chronic hypoparathyroidism is established only after 6 months after neck surgery.
Diagnostic Criteria
- The diagnosis of hypoparathyroidism is made when the following diagnostic criteria are met:[1][2]
- Hypocalcemia (albumin-adjusted) confirmed on at least two occasions separated by at least 2 weeks.
- Parathyroid hormone (PTH) concentration, by second- or third-generation immunoassay, that is undetectable or inappropriately low (ie, <20 pg/mL) in the presence of hypocalcemia on at least two occasions.
- Phosphate levels in the upper normal or frankly elevated range (helpful but not mandatory).
- After neck surgery, chronic hypoparathyroidism is established only after 6 months.
References
- ↑ Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT (2016). "Management of Hypoparathyroidism: Summary Statement and Guidelines". J. Clin. Endocrinol. Metab. 101 (6): 2273–83. doi:10.1210/jc.2015-3907. PMID 26943719.
- ↑ Bilezikian JP, Khan A, Potts JT, Brandi ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J (2011). "Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research". J. Bone Miner. Res. 26 (10): 2317–37. doi:10.1002/jbmr.483. PMC 3405491. PMID 21812031.